# PERDOCEO EDUCATION Corp: financial statements, quarterly

PRDO · Nasdaq · CIK 1046568 · [Other](/sectors/other.md) · fiscal year ends Dec 31

Pages: [Overview](/companies/prdo.md) · [Financials](/companies/prdo/financials.md) · [Filings](/companies/prdo/filings.md) · [Insiders](/companies/prdo/insiders.md)

Standardized line items from XBRL company facts. Each value links to its filing; d marks a value derived from year-to-date figures. Other view: [annual](/companies/prdo/financials.md?period=annual).

## Income statement

| Line item | Unit | Q3 FY2023 (2023-09-30) | Q4 FY2023 (2023-12-31) | Q1 FY2024 (2024-03-31) | Q2 FY2024 (2024-06-30) | Q3 FY2024 (2024-09-30) | Q4 FY2024 (2024-12-31) | Q1 FY2025 (2025-03-31) | Q2 FY2025 (2025-06-30) | Q3 FY2025 (2025-09-30) | Q4 FY2025 (2025-12-31) | Q1 FY2026 (2026-03-31) | Q2 FY2026 (2026-06-30) |
| --- | --- | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: |
| Revenue | $m | [180](/filings/0000950170-24-125309.md) | [148 d](/filings/0001193125-26-059331.md) | [168](/filings/0000950170-25-061803.md) | [167](/filings/0000950170-25-100876.md) | [170](/filings/0001193125-25-264625.md) | [176 d](/filings/0001193125-26-059331.md) | [213](/filings/0001193125-26-211837.md) | [210](/filings/0001193125-26-337926.md) | [212](/filings/0001193125-25-264625.md) | [212 d](/filings/0001193125-26-059331.md) | [222](/filings/0001193125-26-211837.md) | [213](/filings/0001193125-26-337926.md) |
| Operating income | $m | [43.1](/filings/0000950170-24-125309.md) | [15.9 d](/filings/0001193125-26-059331.md) | [46.3](/filings/0000950170-25-061803.md) | [46.0](/filings/0000950170-25-100876.md) | [44.8](/filings/0001193125-25-264625.md) | [37.2 d](/filings/0001193125-26-059331.md) | [51.7](/filings/0001193125-26-211837.md) | [51.4](/filings/0001193125-26-337926.md) | [51.0](/filings/0001193125-25-264625.md) | [41.9 d](/filings/0001193125-26-059331.md) | [63.1](/filings/0001193125-26-211837.md) | [54.9](/filings/0001193125-26-337926.md) |
| Interest expense | $m | [0.1](/filings/0000950170-23-058232.md) | [0.1 d](/filings/0000950170-24-017946.md) | [0.3](/filings/0000950170-24-051293.md) | [0.1](/filings/0000950170-24-088599.md) | [0.1](/filings/0001193125-25-264625.md) | [0.1 d](/filings/0001193125-26-059331.md) | [1.7](/filings/0001193125-26-211837.md) | [1.6](/filings/0001193125-26-337926.md) | [1.6](/filings/0001193125-25-264625.md) | [1.6 d](/filings/0001193125-26-059331.md) | [1.5](/filings/0001193125-26-211837.md) | [1.5](/filings/0001193125-26-337926.md) |
| Income tax | $m | [6.8](/filings/0000950170-24-125309.md) | [5.2 d](/filings/0001193125-26-059331.md) | [13.4](/filings/0000950170-25-061803.md) | [14.6](/filings/0000950170-25-100876.md) | [14.1](/filings/0001193125-25-264625.md) | [11.7 d](/filings/0001193125-26-059331.md) | [12.8](/filings/0001193125-26-211837.md) | [15.2](/filings/0001193125-26-337926.md) | [16.2](/filings/0001193125-25-264625.md) | [12.7 d](/filings/0001193125-26-059331.md) | [14.2](/filings/0001193125-26-211837.md) | [12.2](/filings/0001193125-26-337926.md) |
| Net income | $m | [41.3](/filings/0000950170-24-125309.md) | [17.2 d](/filings/0001193125-26-059331.md) | [39.4](/filings/0000950170-25-061803.md) | [38.4](/filings/0000950170-25-100876.md) | [38.3](/filings/0001193125-25-264625.md) | [31.5 d](/filings/0001193125-26-059331.md) | [43.7](/filings/0001193125-26-211837.md) | [41.0](/filings/0001193125-26-337926.md) | [39.9](/filings/0001193125-25-264625.md) | [35.3 d](/filings/0001193125-26-059331.md) | [54.0](/filings/0001193125-26-211837.md) | [48.0](/filings/0001193125-26-337926.md) |
| Diluted EPS | $ per share | [0.62](/filings/0000950170-24-125309.md) | not reported | [0.59](/filings/0000950170-25-061803.md) | [0.57](/filings/0000950170-25-100876.md) | [0.57](/filings/0001193125-25-264625.md) | not reported | [0.65](/filings/0001193125-26-211837.md) | [0.62](/filings/0001193125-26-337926.md) | [0.60](/filings/0001193125-25-264625.md) | not reported | [0.85](/filings/0001193125-26-211837.md) | [0.75](/filings/0001193125-26-337926.md) |
| Basic EPS | $ per share | [0.63](/filings/0000950170-24-125309.md) | not reported | [0.60](/filings/0000950170-25-061803.md) | [0.59](/filings/0000950170-25-100876.md) | [0.58](/filings/0001193125-25-264625.md) | not reported | [0.67](/filings/0001193125-26-211837.md) | [0.63](/filings/0001193125-26-337926.md) | [0.62](/filings/0001193125-25-264625.md) | not reported | [0.86](/filings/0001193125-26-211837.md) | [0.77](/filings/0001193125-26-337926.md) |

- Revenue: us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax
- Operating income: us-gaap:OperatingIncomeLoss
- Interest expense: us-gaap:InterestExpense, us-gaap:InterestExpenseNonoperating
- Income tax: us-gaap:IncomeTaxExpenseBenefit
- Net income: us-gaap:NetIncomeLoss
- Diluted EPS: us-gaap:EarningsPerShareDiluted
- Basic EPS: us-gaap:EarningsPerShareBasic

## Balance sheet

| Line item | Unit | Q3 FY2023 (2023-09-30) | FY2023 (2023-12-31) | Q1 FY2024 (2024-03-31) | Q2 FY2024 (2024-06-30) | Q3 FY2024 (2024-09-30) | FY2024 (2024-12-31) | Q1 FY2025 (2025-03-31) | Q2 FY2025 (2025-06-30) | Q3 FY2025 (2025-09-30) | FY2025 (2025-12-31) | Q1 FY2026 (2026-03-31) | Q2 FY2026 (2026-06-30) |
| --- | --- | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: |
| Cash and equivalents | $m | [166](/filings/0000950170-23-058232.md) | [118](/filings/0000950170-25-022187.md) | [126](/filings/0000950170-24-051293.md) | [128](/filings/0000950170-24-088599.md) | [238](/filings/0000950170-24-125309.md) | [109](/filings/0001193125-26-059331.md) | [132](/filings/0000950170-25-061803.md) | [172](/filings/0000950170-25-100876.md) | [159](/filings/0001193125-25-264625.md) | [111](/filings/0001193125-26-337926.md) | [164](/filings/0001193125-26-211837.md) | [163](/filings/0001193125-26-337926.md) |
| Current assets | $m | [670](/filings/0000950170-23-058232.md) | [655](/filings/0000950170-25-022187.md) | [706](/filings/0000950170-24-051293.md) | [732](/filings/0000950170-24-088599.md) | [774](/filings/0000950170-24-125309.md) | [640](/filings/0001193125-26-059331.md) | [686](/filings/0000950170-25-061803.md) | [721](/filings/0000950170-25-100876.md) | [736](/filings/0001193125-25-264625.md) | [697](/filings/0001193125-26-337926.md) | [747](/filings/0001193125-26-211837.md) | [803](/filings/0001193125-26-337926.md) |
| Total assets | $m | [1,026](/filings/0000950170-23-058232.md) | [1,007](/filings/0000950170-25-022187.md) | [1,052](/filings/0000950170-24-051293.md) | [1,078](/filings/0000950170-24-088599.md) | [1,117](/filings/0000950170-24-125309.md) | [1,237](/filings/0001193125-26-059331.md) | [1,269](/filings/0000950170-25-061803.md) | [1,294](/filings/0000950170-25-100876.md) | [1,299](/filings/0001193125-25-264625.md) | [1,248](/filings/0001193125-26-337926.md) | [1,289](/filings/0001193125-26-211837.md) | [1,334](/filings/0001193125-26-337926.md) |
| Current liabilities | $m | [139](/filings/0000950170-23-058232.md) | [111](/filings/0000950170-25-022187.md) | [143](/filings/0000950170-24-051293.md) | [135](/filings/0000950170-24-088599.md) | [141](/filings/0000950170-24-125309.md) | [132](/filings/0001193125-26-059331.md) | [154](/filings/0000950170-25-061803.md) | [169](/filings/0000950170-25-100876.md) | [165](/filings/0001193125-25-264625.md) | [138](/filings/0001193125-26-337926.md) | [155](/filings/0001193125-26-211837.md) | [171](/filings/0001193125-26-337926.md) |
| Short-term borrowings | $m | not reported | not reported | not reported | not reported | not reported | not reported | not reported | not reported | not reported | not reported | not reported | not reported |
| Shareholders' equity | $m | [830](/filings/0000950170-24-125309.md) | [841](/filings/0001193125-26-059331.md) | [866](/filings/0000950170-25-100876.md) | [900](/filings/0001193125-25-264625.md) | [935](/filings/0001193125-25-264625.md) | [960](/filings/0001193125-26-337926.md) | [970](/filings/0001193125-26-337926.md) | [985](/filings/0001193125-26-337926.md) | [998](/filings/0001193125-25-264625.md) | [972](/filings/0001193125-26-337926.md) | [1,000](/filings/0001193125-26-337926.md) | [1,033](/filings/0001193125-26-337926.md) |

- Cash and equivalents: us-gaap:CashAndCashEquivalentsAtCarryingValue
- Current assets: us-gaap:AssetsCurrent
- Total assets: us-gaap:Assets
- Current liabilities: us-gaap:LiabilitiesCurrent
- Short-term borrowings: not reported
- Shareholders' equity: us-gaap:StockholdersEquity

## Cash flow

| Line item | Unit | Q3 FY2023 (2023-09-30) | Q4 FY2023 (2023-12-31) | Q1 FY2024 (2024-03-31) | Q2 FY2024 (2024-06-30) | Q3 FY2024 (2024-09-30) | Q4 FY2024 (2024-12-31) | Q1 FY2025 (2025-03-31) | Q2 FY2025 (2025-06-30) | Q3 FY2025 (2025-09-30) | Q4 FY2025 (2025-12-31) | Q1 FY2026 (2026-03-31) | Q2 FY2026 (2026-06-30) |
| --- | --- | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: |
| Operating cash flow | $m | [32.6 d](/filings/0000950170-24-125309.md) | [13.2 d](/filings/0001193125-26-059331.md) | [54.5](/filings/0000950170-25-061803.md) | [38.5 d](/filings/0000950170-25-100876.md) | [51.0 d](/filings/0001193125-25-264625.md) | [17.6 d](/filings/0001193125-26-059331.md) | [65.1](/filings/0001193125-26-211837.md) | [78.8 d](/filings/0001193125-26-337926.md) | [41.2 d](/filings/0001193125-25-264625.md) | [40.1 d](/filings/0001193125-26-059331.md) | [69.4](/filings/0001193125-26-211837.md) | [74.6 d](/filings/0001193125-26-337926.md) |
| Capital expenditure | $m | not reported | not reported | not reported | not reported | not reported | not reported | not reported | not reported | not reported | not reported | not reported | not reported |
| Dividends paid | $m | not reported | [7.2 d](/filings/0000950170-24-017946.md) | [7.2](/filings/0000950170-24-051293.md) | not reported | not reported | not reported | not reported | not reported | not reported | not reported | not reported | not reported |
| Share repurchases | $m | [0.0 d](/filings/0000950170-24-125309.md) | [5.6 d](/filings/0001193125-26-059331.md) | [6.8](/filings/0000950170-25-061803.md) | [0.0 d](/filings/0000950170-25-100876.md) | [0.0 d](/filings/0001193125-25-264625.md) | [0.0 d](/filings/0001193125-26-059331.md) | [25.2](/filings/0001193125-26-211837.md) | [20.9 d](/filings/0001193125-26-337926.md) | [20.6 d](/filings/0001193125-25-264625.md) | [54.1 d](/filings/0001193125-26-059331.md) | [8.1](/filings/0001193125-26-211837.md) | [6.8 d](/filings/0001193125-26-337926.md) |

- Operating cash flow: us-gaap:NetCashProvidedByUsedInOperatingActivities
- Capital expenditure: not reported
- Dividends paid: us-gaap:PaymentsOfDividends
- Share repurchases: us-gaap:PaymentsForRepurchaseOfCommonStock

## Shares

| Line item | Unit | Q3 FY2022 (2022-09-30) | Q1 FY2023 (2023-03-31) | Q2 FY2023 (2023-06-30) | Q3 FY2023 (2023-09-30) | Q1 FY2024 (2024-03-31) | Q2 FY2024 (2024-06-30) | Q3 FY2024 (2024-09-30) | Q1 FY2025 (2025-03-31) | Q2 FY2025 (2025-06-30) | Q3 FY2025 (2025-09-30) | Q1 FY2026 (2026-03-31) | Q2 FY2026 (2026-06-30) |
| --- | --- | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: |
| Diluted shares (weighted) | millions of shares | [68.6](/filings/0000950170-23-058232.md) | [68.5](/filings/0000950170-24-051293.md) | [68.5](/filings/0000950170-24-088599.md) | [67.1](/filings/0000950170-24-125309.md) | [66.8](/filings/0000950170-25-061803.md) | [67.1](/filings/0000950170-25-100876.md) | [67.3](/filings/0001193125-25-264625.md) | [66.9](/filings/0001193125-26-211837.md) | [66.6](/filings/0001193125-26-337926.md) | [66.0](/filings/0001193125-25-264625.md) | [63.4](/filings/0001193125-26-211837.md) | [63.6](/filings/0001193125-26-337926.md) |

- Diluted shares (weighted): us-gaap:WeightedAverageNumberOfDilutedSharesOutstanding

Shares outstanding: 62,577,055 at 2026-07-31, from the cover of the [10-Q filed 2026-08-06](/filings/0001193125-26-337926.md) (dei:EntityCommonStockSharesOutstanding).

Source: SEC EDGAR, XBRL company facts. Last ingested by Listed: Oct 24, 2026, 15:31 ET. No prices; not investment advice.